Implementation of Ask-Advise-Connect in a safety net healthcare system: quitline treatment engagement and smoking cessation outcomes. Issue 1 (22nd November 2018)

• Record Type: Journal Article
• Authors: Piñeiro, Bárbara; Vidrine, Damon J; Wetter, David W; Hoover, Diana S; Frank-Pearce, Summer G; Nguyen, Nga; Zbikowski, Susan M; Vidrine, Jennifer I
• Is Part Of: Translational behavioral medicine. Volume 10:Issue 1(2020)
• Page Start: 163
• Page End: 167
• Publication Date: 2018-11-22
• Subjects: Implementation -- Smoking cessation -- Quitline -- Phone counseling -- Ask-Advise-Connect -- Treatment engagement; Medicine and psychology -- Periodicals; 616.0019
• DOI: 10.1093/tbm/iby108
• Languages: English
• ISSNs: 1869-6716

Abstract

Abstract : Smokers who enrolled in treatment via Ask Advise Connect reported abstinence rates that were consistent with other quitline treatment studies, yet biochemically confirmed abstinence was dramatically lower. Abstract: Ask-Advise-Connect (AAC) was designed to link smokers in primary care settings with evidence-based tobacco treatment delivered via state quitlines. AAC involves training medical staff to Ask about smoking status, Advise smokers to quit, and offer to immediately Connect smokers with quitlines through an automated link within the electronic health record. We evaluated the efficacy of AAC in facilitating treatment engagement and smoking abstinence in a 34 month implementation trial conducted in a large, safety-net health care system. AAC was implemented from April 2013 through February 2016 in 13 community clinics that provided care to low-income, predominantly racial/ethnic minority smokers. Licensed vocational nurses were trained to implement AAC as part of standard care. Outcomes included (a) treatment engagement (i.e., proportion of identified smokers that enrolled in treatment) and (b) self-reported and biochemically confirmed abstinence at 6 months. Smoking status was recorded for 218, 915 unique patients, and 40, 888 reported current smoking. The proportion of all identified smokers who enrolled in treatment was 11.8%. Self-reported abstinence at 6 months was 16.6%, and biochemically confirmed abstinence was 4.5%. AAC was successfully implemented as part of standard care. Treatment engagement was high compared with rates of engagement for more traditional referral-based approaches reported in the literature. Although self-reported abstinence was in line with other quitline-delivered treatment studies, biochemically confirmed abstinence, which is not routinely captured in quitline studies, was dramatically lower. This discrepancy challenges the adequacy of self-report for large, population-based studies. A more detailed and comprehensive investigation is warranted.